We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 13 start-ups with an aggregate funding of $536.4m. The average funding per company in this subset is $41.3m.
Last update to the database: Feb 18, 2025. See changelog.
Metabolon is a company developing metabolomics analytical methods and software for biomarker discovery
5
Funding Rounds
$57.1m
Money raised
Biocrates Life Sciences AG is an Innsbruck-based medical diagnostics company focused on metabolomic research and technology.
8
Funding Rounds
$13.6m
Money raised
ReviveMed is a biotech start-up that analyses metabolomic data using artificial intelligence, which allows them to design new medical therapeutics.
2
Funding Rounds
$1.5m
Money raised
Almac is a biomedical services company based in the UK founded in 1968 by Allen McClay.
2
Funding Rounds
$1.4m
Money raised
Nimbus Therapeutics is a Computer-Based Drug Discovery founded in 2011 by Bruce Booth.
4
Funding Rounds
$53.0m
Money raised
Sygnature Discovery Limited is a drug Discovery Contract Research founded in 2004 by Simon Hirst.
1
Funding Rounds
Cirius Therapeutics is a company developing an insulin sensitizer for the treatment of non-alcoholic steatohepatitis.
1
Funding Rounds
$40.0m
Money raised
Sagimet Biosciences Inc. is a drugs targeting the fatty acid synthase enzyme.
3
Funding Rounds
$185.0m
Money raised
SFA Therapeutics is a microbiome-derived metabolites as drugs founded in 2016 by Ira Spector, Mark Feitelson and Alla Arzumanyan.
1
Funding Rounds
$4.0m
Money raised
Poxel is a biopharmaceutical company developing drugs for metabolic diseases founded in 2009.
1
Funding Rounds
$20.3m
Money raised
Developer of therapeutics for chronic autoimmune and inflammatory diseases.
2
Funding Rounds
$80.0m
Money raised
Azafaros is a small Molecules.
1
Funding Rounds
$27.5m
Money raised
Adlai Nortye Biopharma is a China-based company.
1
Funding Rounds
$53.0m
Money raised